DBV Technologies S.A.

DBVTF ·Healthcare, Drug Manufacturers - General
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024
Assets
Cash & Equivalents $174.9M $229.2M $194.2M $69.8M $103.2M $13.0M $32.5M $46.4M
Accounts Receivable — — — — — — — —
Inventory — — — — — — — —
Total Current Assets $201.9M $246.7M $212.9M $88.9M $121.2M $29.1M $44.4M $68.8M
Property, Plant & Equipment $9.7M $9.9M $10.4M $10.5M $11.1M $10.8M $11.3M $13.0M
Goodwill — — — — — — — —
Intangible Assets (Excl. Goodwill) — $100.0K $0 $21.0K $26.0K $29.0K $40.0K $43.0K
Total Assets $223.2M $266.4M $233.7M $110.5M $143.4M $50.6M $65.7M $93.1M
Liabilities
Accounts Payable $11.8M $39.5M $11.3M $39.8M $40.8M $34.1M $22.0M $22.5M
Total Current Liabilities $54.3M $51.8M $58.0M $49.5M $49.4M $40.4M $31.1M $30.9M
Long-Term Debt — — — — — — — —
Total Liabilities $62.8M $58.4M $64.9M $57.6M $57.2M $47.7M $38.3M $39.0M
Stockholders' Equity
Retained Earnings $-270.3M $-440.7M $-393.1M $-348.3M $-315.1M $-313.5M $-286.4M $-263.3M
Total Stockholders' Equity $160.4M $207.9M $168.8M $52.9M $86.2M $2.9M $27.4M $54.0M
← Newer Page 1 of 3 Older →